You are here: Industry Insights > BioNTech

News List

Vaccine trials essential to evaluate effectiveness against new COVID-19 variants: GlobalData expresspharma
February 10, 2021
The largest proportion of the ongoing vaccine trials are now in Phase II (38.6 per cent) and Phase III (36.3 per cent), after Phase I studies dominated the earlier period of the pandemic.
Merck and BioNTech to boost lipid supply for Covid-19 vaccine production pharmaceutical-technology
February 09, 2021
Merck and BioNTech have announced a further expansion of their strategic partnership to accelerate the supply of urgently needed lipids and boost the amount of their delivery by the year-end.
UK launches trial to study alternating COVID-19 vaccines for different doses europeanpharmaceuticalreview
February 07, 2021
The UK Government has given £7 million of funding for a clinical trial which will investigate whether patients can be given different COVID-19 vaccines for each dose.
Malaysia sets February 2022 target to complete COVID-19 vaccine rollout expresspharma
February 05, 2021
Malaysia’s government said on Thursday it expects to complete its COVID-19 immunisation programme by February next year, covering 80 per cent of its population of about 32 million people.
New Zealand approves COVID-19 vaccine, warns against nationalism expresspharma
February 04, 2021
The World Health Organization has warned against “hoarding” as a growing number of countries agreed bilateral deals to buy millions of doses of COVID-19 vaccines.
Pfizer targets at least 2 billion COVID-19 vaccine doses this year, sees $15 billion in 2021 from the shots expresspharma
February 04, 2021
Pfizer said that it expects to generate $15 billion, or about a quarter of its total revenue this year, from sales of its COVID-19 vaccine co-developed with German partner BioNTech.
In vitro studies demonstrate Pfizer and BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with key mutations present in U.K. and South African variants worldpharmanews
February 03, 2021
Pfizer Inc. and BioNTech SE announced results from in vitro neutralization studies of sera from individuals vaccinated with the Pfizer-BioNTech COVID-19 vaccine.
Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine contractpharma
February 01, 2021
Novartis to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of COVID-19 vaccine.
Novavax COVID-19 vaccine 89 per cent effective in UK trial, 60 per cent in South Africa expresspharma
January 29, 2021
Novavax is stockpiling vaccine at six operating manufacturing locations and said it expects a total of eight plants in seven countries to produce at the rate of two billion doses per year, including from the Serum Institute of India.
Sanofi to produce 100 million Pfizer/BioNTech vaccine doses: CEO expresspharma
January 27, 2021
Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, said Paul Hudson, CEO of Sanofi in an interview with Le Figaro newspaper.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page